Company Filing History:
1 out of 9 
1 out of 560 
1 out of 5,309 
Years Active: 2003-2005
Title: Richard Glynne: Innovations in B Cell Activity and Data Analysis
Introduction
Richard Glynne, an accomplished inventor based in Palo Alto, California, has made significant contributions to the field of immunology and data analysis through his innovative patents. He holds two patents that focus on advancing our understanding of B cell activity and improving the analysis of biomolecular data, showcasing his commitment to scientific progress.
Latest Patents
Glynne's most recent patents include "Methods of Screening for B Cell Activity Modulators" and "Method and Apparatus for Analysis of Data from Biomolecular Arrays."
The first patent provides groundbreaking methods for identifying genes that are differentially expressed within B cells, allowing for a deeper characterization of their regulation and function. This innovation has the potential to enhance the prognosis, diagnosis, monitoring, and treatment of immune system disorders by identifying useful targets within the B cell response.
His second patent involves new computer programs and methods for analyzing data from biomolecular binding experiments. This invention enables researchers to extract and compare data effectively, generating probability values that indicate the presence of molecular species in target samples. It employs statistical methods to normalize experimental values, producing comprehensive data files for further analysis.
Career Highlights
Throughout his career, Richard Glynne has worked with notable companies such as Eos Biotechnology, Inc. and Affymetrix, Inc. His positions at these organizations have allowed him to collaborate on significant projects related to biomolecular research and data analysis.
Collaborations
Glynne has had the opportunity to work alongside talented individuals, including Ghassan Ghandour and Chris Goodnow. These collaborations have likely contributed to the innovative nature of his patents, fostering idea exchanges that push the boundaries of scientific discovery in his field.
Conclusion
Richard Glynne's contributions to the fields of immunology and data analysis underscore the importance of innovation in advancing scientific knowledge. His patents not only provide valuable tools for researchers but also pave the way for future developments in understanding B cell activity and enhancing data evaluation techniques. As he continues his work, Glynne is poised to make further impactful contributions to the scientific community.